BPP 5a

BPP 5a is an amide-based enzyme inhibitor with potent activity against bradykinin b2 receptor. It binds to the b2 receptor and inhibits its enzymatic activity, leading to a decrease in blood pressure. BPP 5a is orally administered and has been shown to be safe and effective in clinical trials. It also has potentiation effects that are mediated by the inhibition of kininases, which leads to a decrease in circulating levels of bradykinin. BPP 5a is used as a diagnostic aid for porcine kidney disease and has been shown to inhibit the production of monoclonal antibodies.